Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Mifepristone 5 mg Versus 10 mg for the Treatment of Uterine Leiomyomata. A Randomized, Double Blinded Clinical Trial.

NCT00712595 is registered in ClinicalTrials.gov with Mediterranea Medica S. L. as lead sponsor.

NCT NCT00712595
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00712595 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Mifepristone 5 mg Versus 10 mg for the Treatment of Uterine Leiomyomata. A Randomized, Double Blinded Clinical Trial.
Lead sponsor
Mediterranea Medica S. L.
Phase
Phase 2/3
Overall status
Completed
Start date
January 31, 2007
Completion date
March 31, 2009
Enrollment
200 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

uterine fibroids